N-{[1-(2-methoxyethyl)-1H-1,3-benzodiazol-2-yl]methyl}prop-2-enamide
Structure Info
- Chemspace ID
- CSSB21332042253 (In-Stock Building Blocks)
- IUPAC Name
- N-{[1-(2-methoxyethyl)-1H-1,3-benzodiazol-2-yl]methyl}prop-2-enamide
- Mol formula
- C14H17N3O2
- Mol weight
- 259 Da
- Catalog Number(s)
- BBLS21332042253, EN300-54539199, bbls21332042253, m273270____30113318____10884640
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.21
- Heavy atoms count
- 19
- Rotatable bond count
- 6
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.285
- Polar surface area (Å)
- 56
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-{[1-(2-methoxyethyl)-1H-1,3-benzodiazol-2-yl]methyl}prop-2-enamide (C14H17N3O2) - CSSB21332042253](/st/structure/200/449f7897e1d06b473a66bd54369b96b2/COCCN1C%2528CNC%2528%253DO%2529C%253DC%2529%253DNC2%253DC1C%253DCC%253DC2.png "C14H17N3O2")
- Zoom the structure
- CSSB21332042253
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 624.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 653.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 684.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 713.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 743.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,454.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,152.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 3,191.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-(2-{1-[2-(2-methoxyethoxy)ethyl]-1H-1,3-benzodiazol-2-yl}ethyl)prop-2-enamide - CSSB21332071028](/st/structure/200/00fabd70e198d86959f106a85fe954c5/COCCOCCN1C%2528CCNC%2528%253DO%2529C%253DC%2529%253DNC2%253DC1C%253DCC%253DC2.png)
![Chemical structure of N-{[1-(propan-2-yl)-1H-1,3-benzodiazol-2-yl]methyl}prop-2-enamide - CSSB00103743424](/st/structure/200/9fda3b93b0e4a67573a87e7da118df7d/CC%2528C%2529N1C%2528CNC%2528%253DO%2529C%253DC%2529%253DNC2%253DCC%253DCC%253DC12.png)
![Chemical structure of 2-chloro-N-{[1-(2-methoxyethyl)-1H-1,3-benzodiazol-2-yl]methyl}acetamide - CSSB21332098733](/st/structure/200/136b5e7d19c2c2f937006a86d37eec97/COCCN1C%2528CNC%2528%253DO%2529CCl%2529%253DNC2%253DC1C%253DCC%253DC2.png)
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide - CSSB00038111745](/st/structure/200/b9819e39880077b820102da197d31364/CN1C%2528CNC%2528%253DO%2529C%253DC%2529%253DNC2%253DCC%253DCC%253DC12.png)
![Chemical structure of 2-chloro-2-fluoro-N-{[1-(2-methoxyethyl)-1H-1,3-benzodiazol-2-yl]methyl}acetamide - CSSB21332109247](/st/structure/200/7a58a5e59904bf41f40b9aa6577989e0/COCCN1C%2528CNC%2528%253DO%2529C%2528F%2529Cl%2529%253DNC2%253DC1C%253DCC%253DC2.png)
![Chemical structure of N-{[1-(2-methoxyethyl)-1H-1,3-benzodiazol-2-yl]methyl}ethene-1-sulfonamide - CSSB21332053498](/st/structure/200/681f2c0fc36dab8157417ec5608ef077/COCCN1C%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DNC2%253DC1C%253DCC%253DC2.png)
![Chemical structure of N-(2-{1-[2-(propan-2-yloxy)ethyl]-1H-1,3-benzodiazol-2-yl}ethyl)prop-2-enamide - CSSB21332071252](/st/structure/200/973fb50d4fcf355ccafba31160ef64e2/CC%2528C%2529OCCN1C%2528CCNC%2528%253DO%2529C%253DC%2529%253DNC2%253DC1C%253DCC%253DC2.png)
